As of now... Celgene is trading at a 3 year low since they lost the patent on one of their cancer medication pills.
They are in talks with Juno therapeutics who they already own a lot of shares of. Juno stock shot up 50% recently with rumors of a complete buyout, with Juno integrating their medication for blood cancer into Celgene's medicine catalogue.
I haven't seen any finance guru or investment funds really go in big on this three year low slump. Do you think its the right time to buy? Or things are gonna get a lot worse for Celgene before it gets better?
Submitted January 18, 2018 at 03:10PM by bignormz http://ift.tt/2rmrjLJ
No comments:
Post a Comment